首页> 美国卫生研究院文献>Springer Open Choice >A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

【2h】

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

机译：OSI-461与米托蒽醌联合用于可能对米托蒽醌有反应的晚期实体瘤患者的I期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo find the maximum tolerated dose (MTD) of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors.

机译：目的寻找晚期实体瘤患者OSI-461与米托蒽醌联合使用的最大耐受剂量（MTD）。

著录项

期刊名称 Springer Open Choice
作者
Lee P. Resta; Roberto Pili; Mario A. Eisenberger; Avery Spitz; Serina King; Jennifer Porter; Amy Franke; Ramesh Boinpally; Michael A. Carducci; Christopher J. Sweeney;
展开▼
作者单位

展开▼
年(卷),期 -1(67),2
年度 -1
页码 431–438
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词
Mitoxantrone OSI-461 Apoptosis Clinical trial;

机译：米托蒽醌;OSI-461;细胞凋亡;临床试验;

相似文献

外文文献
中文文献
专利

1. A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone. [J] . Resta LP, Pili R, Eisenberger MA, Cancer chemotherapy and pharmacology. . 2011,第2期

机译：OSI-461与米托蒽醌联合用于患有可能对米托蒽醌有反应的晚期实体瘤患者的I期研究。
2. A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone [J] . Lee P. Resta, Roberto Pili, Mario A. Eisenberger, Cancer Chemotherapy and Pharmacology . 2011,第2期

机译：OSI-461与米托蒽醌联合用于可能对米托蒽醌有反应的晚期实体瘤患者的I期研究
3. A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors. [J] . Peacock NW, Burris HA, Dieras V, Investigational new drugs. . 1998,第1期

机译：长春瑞滨联合米托蒽醌在难治性实体瘤患者中的一项I期试验。
4. SPECTROELECTROCHEMICAL AND THEORETICAL STUDY OF THE REDOX ACTIVATION OF ANTHRAQUINONE ANTITUMORAL DRUG MITOXANTRONE [C] . MIRELA ENACHE, ELENA VOLANSCHI The Meeting of the Electrochemical Society . 2003

机译：氧化铈抗肿瘤药尿催化剂氧化还原活化的光谱电化学与理论研究
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia [O] . Amy Y. Wang, Howard Weiner, Margaret Green, 2018

机译：Selinexor联合大剂量阿糖胞苷和米托蒽醌在急性髓样白血病患者中诱导缓解的I期研究
7. A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone [O] . Lee P. Resta, Roberto Pili, Mario A. Eisenberger, 2010

机译：OSI-461与米托蒽醌联合用于可能对米托蒽醌有反应的晚期实体瘤患者的I期研究

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

摘要

著录项

相似文献

相关主题

期刊订阅